Relation of Myocardial Dysfunction to Biomarkers, COVID-19 Severity and All-Cause Mortality
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14881 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Jianxiong Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai General Hospital of Nanjing Medical University, Shanghai, China. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Severity of Illness Index, Echocardiography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shanghai, Shanghai Health and Family Planning Commission Fund, Shanghai Jiading District Health and Family Planning Commission Fund.
Abstract (Originalsprache)
Aims
The COVID-19 infection has been described as affecting myocardial injury. However, the relation between left ventricular global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS), disease severity and all-cause mortality in COVID-19 is unclear. Methods and Results The study consisted of 220 patients with COVID-19, including 127 (57.5%) with mild, 43 (19.5%) with moderate and 50 (22.7%) with severe/critical conditions. Myocardial dysfunction was analysed by GLS, GCS and GRS using two-dimensional speckle-tracking echocardiography. Hazard ratios and Kaplan–Meier curves were produced to assess the association between strains and cardiac biomarker indices with a composite outcome of all-cause mortality. With an average follow-up period of 11 days, 19 patients reached the endpoint (death). Significant associations were found for the three strain parameters and the levels of blood urea nitrogen (BUN) (r = 0.206, 0.221 and 0.355, respectively). Cardiac troponin I (cTnI) was closely related to the GLS and GCS (r = 0.240 and 0.324, respectively). In multivariable Cox regression, GCS > −21.6% was associated with all-cause death {hazard ratio, 4.007 [95% confidence interval (CI), 11.347–11.919]}.
Conclusions
GLS, GCS and GRS are significantly related to myocardial dysfunction in patients with COVID-19. Worsening GCS poses an increased risk of death in COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
- Department of Ultrasound, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China.
- Department of Ultrasound, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Ultrasound, Jiading Branch of Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Ultrasound, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Echocardiology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Zhaojun Li
Förderung
- Natural Science Foundation of Shanghai
- Shanghai Health and Family Planning Commission Fund
- Shanghai Jiading District Health and Family Planning Commission Fund
- Startup Fund for Scientific Research, Fujian Medical University
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Chen, J., Jin, L., Zhang, M., Wu, L., Shen, C., Sun, J., Du, L., Luo, X., & Li, Z. (2024). Relation of Myocardial Dysfunction to Biomarkers, COVID-19 Severity and All-Cause Mortality. ESC Heart Failure. https://doi.org/10.1002/ehf2.14881
Vancouver
Chen J, Jin L, Zhang M, Wu L, Shen C, Sun J, et al. Relation of Myocardial Dysfunction to Biomarkers, COVID-19 Severity and All-Cause Mortality. ESC Heart Failure. 2024. doi:10.1002/ehf2.14881
BibTeX
@article{Chen2024,
author = {Chen, Jianxiong and Jin, Lin and Zhang, Mengjiao and Wu, Lingheng and Shen, Cuiqin and Sun, Jiali and Du, Lianfang and Luo, Xianghong and Li, Zhaojun},
title = {Relation of Myocardial Dysfunction to Biomarkers, COVID-19 Severity and All-Cause Mortality},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14881}
}
EUVIMED